Early Detection and Surveillance of the SARS-CoV-2 Variant BA.2.86 - Worldwide, July-October 2023

Published on October 26, 2023

Early detection of emerging SARS-CoV-2 variants is critical to assessing risk, providing clear and timely communication messages, and coordinating public health action. CDC used a multicomponent surveillance approach to track the global spread of the SARS-CoV-2 variant BA.2.86.

Continue reading on website
Other news

Notes from the Field: Early Identification of the SARS-CoV-2 Omicron BA.2.86 Variant by the Traveler-Based Genomic Surveillance Program - Dulles International Airport, August 2023

October 26, 2023
CDC detected BA.2.86 variant in a traveler within days of being reported. Timely detection provides early warning of new COVID-19 variants entering the U.S.

RECOMMENDATIONS AND REPORTS: CDC Recommendations for Hepatitis C Testing Among Perinatally Exposed Infants and Children - United States, 2023

October 31, 2023
CDC reports on CDC recommendations for hepatitis C testing among perinatally exposed infants and children in the United States in 2023.